Boehringer to make prostate cancer antibody
Boehringer Ingelheim has won a contract to develop a commercial-scale manufacturing process for a new prostate cancer drug in development at fellow German company Micromet.
Archives for February 26, 2004
Applied Bio fends off patent challenge
Applied Biosystems has won a round in its ongoing legal dispute over a technology used in its automated DNA sequencing instruments.
Hybridon sees broader use for cancer drug
An antisense compound developed by Hybridon could be of value in a much broader range of human cancers than previously thought, according to new research.
Diversa aims at $100m enzyme business
Diversa has entered into a deal aimed at boosting its manufacturing capacity in enzymes used for industrial processes, including the production of pharmaceuticals. The agreement with Mexico's Fermic is designed to step up the size of Diversa's...
deCODE forges pharmacogenomics alliance with Merck
Icelandic company deCODE Genetics has entered into a seven-year alliance to conduct pharmacogenomic studies on Merck & Co's drug candidates using its population genetics database.